Medical device company TearScience has hired a former Allergan (NYSE:AGN) executive to spearhead European commercialization efforts for its novel dry eye treatment. Deithart Reichardt is now senior ...

The dry eye treatment developed by TearScience received 510(k) clearance last week, about seven months after the company’s novel medical device received its first marketing go-ahead from the U.S. Food ...

SAN DIEGO, CA / ACCESSWIRE / September 26, 2017 / CEOCFO Magazine, an independent investment publication that highlights important technologies and companies, today reports on Innovations in Managing ...

MORRISVILLE, N.C.--(BUSINESS WIRE)--TearScience, Inc., a privately-held medical device company, today announced that it has received U.S. Food and Drug Administration (FDA) clearance for its next ...

Please provide your email address to receive an email when new articles are posted on . MORRISVILLE, N.C. — TearScience has received $44.5 million in Series C funding from new and existing investors ...

Please provide your email address to receive an email when new articles are posted on . LOS ANGELES — TearScience has introduced the LipiFlow Activator II, a ...

Morrisville’s home-grown dry eye innovation will hit the television screen today when it appears on CBS’ “The Doctors.” “It’s kind of fun to sit here and see that we’re getting that kind of exposure,” ...

Dry eye treatment company TearScience, with $70 million secured in new financing, is planning a global push of its products. The privately held, venture capital-backed firm is based in Morrisville.

February ended with big funding news in the med tech world: HealthCare Royalty Partners' commitment of up to $70 million in debt financing to TearScience, the North Carolina maker of a dry eye ...

TearScience will tap up to a whopping $70 million in new financing to ramp up commercial marketing efforts for its dry eye treatment device. HealthCare Royalty Partners is the sole backer of the new ...

Six years after a blockbuster $40 million funder, Morrisville-based TearScience is at it again, raising a new $19.3 million in equity financing. Six years after a blockbuster $40 million funder, ...

Dry eye treatment company TearScience, which is considering plans for an initial public stock offering, now has a new chief financial officer. The medical device company has promoted Nicole Wicker ...